Results 81 to 90 of about 5,855 (210)

Analytical Approaches to Address Challenges in the Analysis of Cannabinoids in Vascular Matrices Using Mass Spectrometry

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Phytocannabinoids are bioactive metabolites derived from the Cannabis sativa plant. They have garnered attention due to their recreational uses and therapeutic potential. Although various analytical strategies have been employed for their analysis, mass spectrometry (MS) coupled to chromatographic separation is superior due to its sensitivity ...
Radwa Mahmoud   +2 more
wiley   +1 more source

Efficacy of lurasidone on anxiety symptoms in patients with schizophrenia: A pooled post hoc analysis of five randomized, placebo‐controlled trials

open access: yesPCN Reports
Aim Comorbid anxiety disorders and their symptoms are common in schizophrenia and may occur before a relapse. The aim of this post hoc analysis is to investigate the efficacy of lurasidone on comorbid anxiety symptoms in patients with schizophrenia ...
Takahiro Nemoto   +2 more
doaj   +1 more source

A Portrait of Anxiety and Depression in Parkinson's Disease: Prevalence, Clinical Correlates, and Treatment Gaps

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms (NMS), specifically anxiety and depression are major drivers of disability in Parkinson's disease (PD). Prevalence estimates remain inconsistent because of differences in population samples, diagnostic criteria, and symptom overlap, contributing to underdiagnosis and undertreatment.
Marshall Schmidt   +4 more
wiley   +1 more source

A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study

open access: yesPharmaceuticals
New clinical reports have recently been published on tofisopam—an anxiolytic drug currently registered as a benzodiazepine—after a long break in this research area.
Andrzej Kokoszka
doaj   +1 more source

Use of anxiolytics and hypnotics - a pilot study

open access: yes, 2007
Introduction: Benzodiazepine anxiolytics and hypnotics are often used in therapy. Aim: To study the use of anxiolytics and hypnotics among pharmacy clients in the town of Plovdiv.Materials and methods: In 2005 a questionnaire study was carried out on the
Krasteva, E.; Medical University of Plovdiv   +2 more
core   +1 more source

Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker‐Positive, Sporadic Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Parkinson's disease (PD) is frequently accompanied by neuropsychiatric symptoms (NPS), including cognitive impairment, which often emerge early and co‐occur. Their long‐term evolution remains incompletely characterized, particularly in biomarker‐positive cohorts.
Izabelle Schoen   +10 more
wiley   +1 more source

Drug Interactions of Psychiatric and COVID-19 Medications

open access: yesBasic and Clinical Neuroscience, 2020
Introduction: Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon.
Niayesh Mohebbi   +4 more
doaj  

Chronic use of hypnotics and anxiolytics

open access: yes, 2017
On request of the Chief-Inspectorate for Mental Health in the Netherlands an overview was made on the research in the Netherlands about the use of psychotropic compounds, viz.
Wieringa NF   +7 more
core  

Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)‐VK4‐116, as a Non‐Opioid Medication for the Treatment of Opioid Use Disorder

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu   +15 more
wiley   +1 more source

Comparative Effectiveness of Propranolol and Non-Benzodiazepine Anxiolytics for Acute Anxiety in Non-Psychiatric Settings (CRD420251039479)

open access: yes
Protocol for a systematic review and meta-analysis on the comparative effectiveness of propranolol and non-benzodiazepine anxiolytics for acute anxiety in non-psychiatric settings .(CRD420251039479)
Owais Nawaz Khan   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy